Evaluation of Tp-E interval and Tp-E/Qtc ratios in patients with overt hypothyroidism and subclinical hypothyroidism

dc.contributor.authorSari, A.
dc.contributor.authorDural, E.
dc.contributor.authorAksu, U.
dc.contributor.authorKorucu, C.
dc.contributor.authorBozkurt, E.
dc.contributor.authorApaydin, M.
dc.date.accessioned2023-09-29T13:39:39Z
dc.date.available2023-09-29T13:39:39Z
dc.date.issued2023en_US
dc.departmentAFSÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractObjective: Tp-e interval and Tp-e/QTc are among the new-generation indicators used for predicting cardiac arrhythmia and ventricular repolarization. In this study, we aimed to evaluate Tp-e and Tp-e/QTc ratios in patients with overt hypothyroidism and subclinical hypothyroid patients. Patients and methods: In this study, a total of 105 patients were included with 35 overt hypothyroidism, 35 subclinical hypothyroidism, and 35 healthy euthyroid patients. The anthropometric measurements, laboratory results, and electrocardiographic data of the patients were measured. The groups were compared in terms of Tp-e interval, Tp-e/QT and Tp-e QT/c ratios. Results: When the Tp-e interval and Tp-e/QTc values of the patients were compared, a significant difference was found (p<0.001). A positive correlation was found between thyroid stimulating hormone (TSH) with Tp-e interval and Tp-e/QT ratio. Conclusions: Tp-e interval and Tp-e/QTc duration increased in overt hypothyroidism and subclinical hypothyroidism patients compared to euthyroid patients. We believe that regular use of levothyroxine therapy in overt hypothyroidism patients will decrease cardiac mortality. Cardiac risk factors should be considered to decide on levothyroxine therapy for subclinical hypothyroidism patients.en_US
dc.identifier.citationSari, A., Dural, İ. E., Aksu, U., Korucu, C., Bozkurt, E., & Apaydin, M. (2023). Evaluation of Tp-E interval and Tp-E/Qtc ratios in patients with overt hypothyroidism and subclinical hypothyroidism. European Review for Medical & Pharmacological Sciences, 27(13).en_US
dc.identifier.doi10.26355/eurrev_202307_32974
dc.identifier.endpage6181en_US
dc.identifier.issn2284-0729
dc.identifier.issue13en_US
dc.identifier.pmid37458674
dc.identifier.scopus2-s2.0-85165035096
dc.identifier.scopusqualityQ2
dc.identifier.startpage6176en_US
dc.identifier.urihttps://dx.doi.org/10.26355/eurrev_202307_32974.
dc.identifier.urihttps://hdl.handle.net/20.500.12933/1619
dc.identifier.volume27en_US
dc.identifier.wosWOS:001045871100027
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorSarı, A.
dc.language.isoen
dc.publisherVerducien_US
dc.relation.ispartofEuropean review for medical and pharmacological sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEvaluation of Tp-E interval and Tp-E/Qtc ratios in patients with overt hypothyroidism and subclinical hypothyroidismen_US
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Sarı.A.2023.pdf
Boyut:
586.01 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: